USP Opens New Facility In Shanghai
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - U.S. Pharmacopeia opened a new international facility in Shanghai's Zhangjiang Hi-Tech Park Sept. 8 to work with Chinese companies and regulators on meeting international standards and ensuring the safety of pharmaceuticals, dietary supplements and ingredients
You may also be interested in...
Sino-U.S. Collaboration On Drug Standards
The Chinese Pharmacopoeia Commission and the U.S. Pharmacopeia Convention jointly hosted the third Sino-U.S. pharmacopoeia summit in Tianjin earlier this month. With the theme of drug quality control and standards, the summit aimed at improving communication and cooperation in drug standards between both nations. All projects in an MOU signed by ChPC and USP last March are underway, some of which are in the implementation stage (PharmAsia News, Sept. 17, 2007). ChPC Secretary-General Wu Zhen pointed out that the two countries should enhance collaboration and coordination in the field of traditional medicine. USP CEO Roger Williams expressed hope that the American standards-setting organization's development in South East Asia will be boosted by greater Chinese support in TCM standards formulation. (Click here for more - Chinese Language)
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).